A Study to Assess Collagenase Clostridium Histolyticum (CCH) in the Treatment of Plantar Fasciitis (PFA)
Public ClinicalTrials.gov record NCT06169319. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Double-blind, Randomized, Placebo-controlled, Dose-ranging Study to Assess the Efficacy, Safety, and Tolerability of EN3835 vs Placebo in the Treatment of Plantar Fasciitis (PFA)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will assess the efficacy, safety, and tolerability of 2 different doses of collagenase clostridium histolyticum (CCH) (previously known as EN3835) compared to placebo.
Study identification
- NCT ID
- NCT06169319
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 231 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 3, 2024 (Actual)
- Primary completion
- Sep 30, 2024 (Actual)
- Completion
- Sep 30, 2024 (Actual)
- Last update posted
- Sep 30, 2025
2024
United States locations
- U.S. sites
- 39
- U.S. states
- 17
- U.S. cities
- 35
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Endo Site 8 | Tucson | Arizona | 85712 | — |
| Endo Site 20 | Castro Valley | California | 94546 | — |
| Endo Site 13 | Corona | California | 92882 | — |
| Endo Site 6 | Encinitas | California | 92024 | — |
| Endo Site 11 | Fresno | California | 93710 | — |
| Endo Site 16 | Los Angeles | California | 90010 | — |
| Endo Site 40 | Los Angeles | California | 90063 | — |
| Endo Site 21 | San Francisco | California | 94115 | — |
| Endo Site 10 | Tarzana | California | 91356 | — |
| Endo Site 37 | Coconut Creek | Florida | 33073 | — |
| Endo Clinical Site 3 | Pinellas Park | Florida | 33782 | — |
| Endo Site 14 | Sweetwater | Florida | 33172 | — |
| Endo Site 7 | Lawrenceville | Georgia | 30043 | — |
| Endo Site 23 | Stonecrest | Georgia | 30038 | — |
| Endo Site 31 | North Chicago | Illinois | 60064 | — |
| Endo Site 28 | O'Fallon | Illinois | 62269 | — |
| Endo Site 33 | Overland Park | Kansas | 66211 | — |
| Endo Site 35 | Shreveport | Louisiana | 71101 | — |
| Endo Clinical Site 2 | Pasadena | Maryland | 21122 | — |
| Endo Site 19 | Grand Rapids | Michigan | 49525 | — |
| Endo Site 27 | Missoula | Montana | 59804 | — |
| Endo Site 38 | Westwood | New Jersey | 07675 | — |
| Endo Site 25 | Moore | Oklahoma | 73160 | — |
| Endo Site 39 | Portland | Oregon | 97202 | — |
| Endo Site 36 | Malvern | Pennsylvania | 19355 | — |
| Endo Clinical Site 4 | Bedford | Texas | 76021 | — |
| Endo Site 24 | Burleson | Texas | 76028 | — |
| Endo Site 17 | Dallas | Texas | 75208 | — |
| Endo Site 26 | Dallas | Texas | 75235 | — |
| Endo Site 18 | Dallas | Texas | 75251 | — |
| Endo Site 30 | Fort Worth | Texas | 76104 | — |
| Endo Clinical Site 1 | Georgetown | Texas | 78628 | — |
| Endo Site 15 | Houston | Texas | 77027 | — |
| Endo Site 9 | McAllen | Texas | 78501 | — |
| Endo Site 34 | San Antonio | Texas | 78229 | — |
| Endo Site 22 | San Antonio | Texas | 78258 | — |
| Endo Clinical Site 5 | Salt Lake City | Utah | 84107 | — |
| Endo Site 32 | Newport News | Virginia | 23606 | — |
| Endo Site 12 | Suffolk | Virginia | 23434 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06169319, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 30, 2025 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06169319 live on ClinicalTrials.gov.